Page 1 of Clinical Trials for BioCryst Pharmaceuticals [SPONSOR-COLLABORATORS], 24 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
Last Updated: February 28, 2012
Condition(s): Acute, Uncomplicated Human Influenza
2
Completed
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
Last Updated: January 12, 2006
Condition(s): Leukemia, Lymphocytic; Lymphoma
3
Completed
Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)
Last Updated: January 18, 2012
Condition(s): Chronic Lymphocytic Leukemia (CLL)
4
Completed
Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
Last Updated: January 18, 2012
Condition(s): Gout
5
Completed
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Last Updated: January 18, 2012
Condition(s): Cutaneous T-cell Lymphoma (CTCL),
6
Terminated
Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza
Last Updated: December 21, 2011
Condition(s): Influenza
7
Completed
Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout
Last Updated: January 18, 2012
Condition(s): Gout
8
Completed
Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)
Last Updated: February 6, 2012
Condition(s): Leukemia, Lymphocytic, Chronic
9
Completed
Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia
Last Updated: January 19, 2012
Condition(s): B-cell Acute Lymphoblastic Leukemia
10
Completed
Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.
Last Updated: November 27, 2007
Condition(s): Influenza
11
Active, not recruiting
Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral BCX4208 Added to Allopurinol
Last Updated: July 5, 2011
Condition(s): Gout; Hyperuricemia; Arthritis; Joint Disease
12
Active, not recruiting
A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral BCX4208 Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
Last Updated: May 8, 2012
Condition(s): Gout; Hyperuricemia; Arthritis; Joint Disease; Renal Insufficiency
13
Recruiting
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
Last Updated: March 19, 2012
Condition(s): Cough; Sore Throat; Nasal Congestion; Headache; Fever; Seasonal Influenza
14
Withdrawn
Intramuscular Peramivir for the Treatment of Uncomplicated Influenza
Last Updated: January 28, 2008
Condition(s): Influenza
15
Completed
Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia
Last Updated: January 18, 2012
Condition(s): Leukemia, T-Cell
16
Terminated
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
Last Updated: January 18, 2012
Condition(s): Leukemia; Lymphoma
17
Terminated
A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.
Last Updated: December 14, 2011
Condition(s): Influenza
18
Completed
Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza
Last Updated: December 21, 2011
Condition(s): Seasonal Influenza; Cough; Sore Throat; Nasal Congestion; Myalgia; Headache; Fatigue
19
Completed
Evaluation of the Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza
Last Updated: December 21, 2011
Condition(s): Influenza
20
Completed
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
Last Updated: July 20, 2011
Condition(s): Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=BioCryst+Pharmaceuticals

Page 1 of Clinical Trials for BioCryst Pharmaceuticals [SPONSOR-COLLABORATORS], 24 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About